SCHEMBL24645974

SCHEMBL24645974

COc1ccc(F)c([C@H]2CC[C@H](COc3cccc([C@@H](CP(C)(=O)O)C4CC4)c3)CC2)c1

nearest known ligand 0.75

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 20/20 0.75

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24646840 1.00 FFAR1 (0.75) FFAR1
SCHEMBL27193700 1.00 FFAR1 (0.75) FFAR1
SCHEMBL30312238 1.00 FFAR1 (0.75) FFAR1
SCHEMBL27193330 1.00 FFAR1 (0.75) FFAR1
SCHEMBL27193328 1.00 FFAR1 (0.75) FFAR1
SCHEMBL24645984 1.00 FFAR1 (0.75) FFAR1
SCHEMBL27273767 1.00 FFAR1 (0.75) FFAR1
SCHEMBL24646883 0.94 FFAR1 (0.77) FFAR1
SCHEMBL30312297 0.94 FFAR1 (0.77) FFAR1
SCHEMBL28969179 0.94 FFAR1 (0.77) FFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220289772-A1 GPR40 AGONISTS KALLYOPE, INC. 2022-09-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220289772-A1 GPR40 AGONISTS GPR119, GPR65, GLP1R FFAR1 10/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.